Viewing Study NCT05018806


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-29 @ 5:37 PM
Study NCT ID: NCT05018806
Status: COMPLETED
Last Update Posted: 2024-06-21
First Post: 2021-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module